Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector, Amgen Australia Pty Ltd, CON-1007
Product name
REPATHA evolocumab (rch) 140 mg/mL injection solution syringe within a pen injector
Sponsor name
Amgen Australia Pty Ltd
Consent start
Consent no.
CON-1007
Standard
paragraph 8(1)(i) of the Therapeutic Goods Order No.91 '“ Standard for labels of prescription and related medicines (TGO 91).
Non-compliance with standard
The products' labels do not comply with the TGO 91 in that the contact details
of the distributor of the medicine are not current on the cartons.
Therapeutic product type
Prescription medicines